Latest Updates & News
FDA Approves First CRISPR Gene Therapy in January 2024 to Treat Beta-Thalassemia
What is Casgevy prescribed for? Casgevy is prescribed to treat people aged 12 years and older with sickle cell disease (SCD) who have frequent vaso-occlusive crises or VOCs. What is the name of the drug and what does it do? Casgevy pronounced cass-JEH-vee, generic name:(exagamglogene autotemcel) is an innovative treatment specifically designed for...
Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023
What is Zepbound prescribed for? Zepbound is prescribed for Chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in...
Velsipity Approved for Moderate-to-Severe Ulcerative Colitis in Adults on October 13, 2023
What is Velsipity prescribed for? Velsipity is prescribed to treat moderately to severely active ulcerative colitis in adults. What is the name of the drug and what does it do? Velsipity, pronounced Vel-sip-itee, (generic name: etrasimod) was approved for the treatment of moderate-to-severe ulcerative colitis (UC). UC is a type of...
Zilbrysq: FDA-Approved on October 17, 2023, for Treating Generalized Myasthenia Gravis
What is Zilbrysq prescribed for? Zilbrysq is prescribed to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive. What is the name of the drug and what does it do? Zilbrysq, pronounced ZIL-brisk, (generic name: zilucoplan) is for generalized myasthenia gravis (MG) treatment in adults. ...
Brixadi Approved for Treatment of Opioid Use Disorder on May 05, 2023
What is Brixadi prescribed for? Brixadi is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. What is the name of the drug and what does it do? Brixadi, pronounced brix-a-dee, (generic name:...
Zurzuvae approved for treatment of postpartum depression on August 04, 2023
What is Zurzuvae prescribed for? Zurzuvae is prescribed to treat postpartum depression in adults. What is the name of the drug and what does it do? Zurzuvae, pronounced ZUR-zoo-vay, (generic name: zuranolone) is a medication approved for treating postpartum depression (PPD) in adults. It belongs to a class of drugs known as neuroactive steroids, which...